MEDIKAMENTENABGABEVORRICHTUNG

Patent europeic · EP4223334 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4223334
Numer da la dumonda
EP23169471
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
21-10-2014
Publitgà
09-08-2023
Concedì
20-05-2026
La protecziun finescha il pli tard
20-10-2034
Proxima taxa annuala scadenta
31-10-2026
Classas IPC
A61M 5/32 (2006.01)
A61M 5/24 (2006.01)
A61M 5/315 (2006.01)
A61M 5/46 (2006.01)
A61M 5/31 (2006.01)
Prioritad
EP 13191199 31.10.2013
Derivà da
EP14793037
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 20-05-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 20.05.2026

Partidas

Possessur

Sanofi-Aventis Deutschland GmbH

P.O. Box Brüningstraße 50, 65926 Frankfurt am Main, DE

Inventur

HUTHMACHER, Winfried

60389 Frankfurt, DE

NOBER, Peter

54597 Rommersheim, DE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.